| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.003 |